ClinicalTrials.gg
Drug

Famotidine clinical trials

Also written Pepcid.

studies test it
52
open now
6
in phase 3
10
first study started
1998

How each study uses Famotidine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Famotidine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
15 Oct 1986 · PEPCID · NDA 019462 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Famotidine
30
Famotidine 20 MG
3
famotidine 40 mg daily
2

Brand

Pepcid
14
Pepcidine
1
gaster
1

Development codes

SUB07503MIG
1

Studies by the year they started

52 studies that test it; most in 2021 (6)

Studies that test Famotidine, by start year
YearStudies
19981
20031
20051
20063
20074
20083
20092
20102
20112
20121
20131
20143
20161
20172
20181
20193
20204
20216
20221
20232
20243
20254
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
15
Phase 3
10
Phase 4
18
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 17 · Other 35

Leidos Life Sciences (3) · Ruttonjee Hospital (3) · Emory University (3) · Amgen (2) · Boston Children's Hospital (2) · Chinese University of Hong Kong (2) · Far Eastern Memorial Hospital (2) · Jesper Ekelund (2)

Often tested with

Tested in the same studies.

Celecoxib (5) · Omeprazole (5) · Dexamethasone (4) · Esomeprazole (4) · Rabeprazole (3) · Ibuprofen (3) · Acetaminophen (3) · Loratadine (2)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Famotidine, phase 3 first.

Studies

Open first, then newest update. How each study uses Famotidine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 52

See all 52 studies that test Famotidine →

Given beside what is tested · 39 — Famotidine is usual care or a partner of the new treatment

Showing 20 of 39.

As the comparator · 9 — what is tested is compared with Famotidine

Codes

What other systems call Famotidine · ClinicalTrials.gg INT008491

  • MeSH (NLM) D015738FamotidineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 5QZO15J2Z8FAMOTIDINEConfirmed FDA, NLM, Wikidata
  • RxNorm 4278Confirmed FDA, Wikidata
  • Wikidata Q411159famotidineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C29045FamotidineOne source FDA
  • DrugBank DB00927One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.